EYEN EYENOVIA INC Investments/Divestments 8-K Filing 2023 - License Agreement with Formosa Pharmaceuticals Eyenovia, Inc. entered into a license agreement with Formosa Pharmaceuticals, granting them an exclusive license to commercialize a novel formulation of Clobetasol Proprionate for ophthalmic use.Get access to all SEC 8-K filings of the EYENOVIA INC